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Abstract
The Berlin Fat Mouse Inbred (BFMI) line is a model for juvenile obesity. Previous studies on crosses between BFMI and 
C57Bl/6N (B6N) have identified a recessive defect causing juvenile obesity on chromosome 3 (jObes1). Bbs7 was identified 
as the most likely candidate gene for the observed effect. Comparative sequence analysis showed a 1578 bp deletion in intron 
8 of Bbs7 in BFMI mice. A CTCF-element is located inside this deletion. To investigate the functional effect of this deletion, 
it was introduced into B6N mice using CRISPR/Cas9. Two mice containing the target deletion were obtained (B6N Bbs7emI8∆1 
and Bbs7emI8∆2) and were subsequently mated to BFMI and B6N to generate two families suitable for complementation. 
Inherited alleles were determined and body composition was measured by quantitative magnetic resonance. Evidence for a 
partial complementation (13.1–15.1%) of the jObes1 allele by the CRISPR/Cas9 modified B6N Bbs7emI8∆1 and Bbs7emI8∆2 
alleles was found. Mice carrying the complementation alleles had a 23–27% higher fat-to-lean ratio compared to animals 
which have a B6N allele (P(Bbs7emI8∆1) = 4.25 ×  10–7; P(Bbs7emI8∆2) = 3.17 ×  10–5). Consistent with previous findings, the reces-
sive effect of the BFMI allele was also seen for the B6N Bbs7emI8∆1 and Bbs7emI8∆2 alleles. However, the effect size of the 
B6N Bbs7emI8∆1 and Bbs7emI8∆2 alleles was smaller than the BFMI allele, and thus showed only a partial complementation. 
Findings suggest additional variants near Bbs7 in addition to or interacting with the deletion in intron 8.
Introduction
The Berlin Fat Mouse Inbred line (BFMI) is a model for 
juvenile obesity. It was selected for high body fat content 
under standard diet (Wagener et  al. 2006). BFMI mice 
have several features of the metabolic syndrome such as 
impaired lipid metabolism and reduced insulin sensitivity 
(Meyer et al. 2009; Hantschel et al. 2011; Heise et al. 2016). 
The BFMI mice develop obesity between 3 and 8 weeks 
(Wagener et al. 2006). Already under a standard breeding 
diet, BFMI males and females at 10 weeks have on average 
8.4 times more body fat mass than C57BL/6NCrl (B6N) ref-
erence mice (Wagener et al. 2006). A region on chromosome 
3 (jObes1 locus) was identified that explains 40% of the vari-
ation of fat mass in an F2 population from a cross between 
the obese BFMI and the lean B6N mouse line (Neuschl 
et al. 2010). Further fine mapping in an advanced intercross 
population generated from the original mapping population 
reduced the confidence interval to ~ 370 kb. Furthermore, 
complementation tests with different knockout mice in the 
target region revealed the Bardet Biedl syndrome 7 (Bbs7) 
gene as the most likely candidate for the juvenile obesity 
phenotype in BFMI mice (Arends et al. 2016).
Sequence comparisons between the BFMI and B6N mouse 
lines in the Bbs7 gene region showed a deletion of 1578 bp 
in intron 8 of the Bbs7 gene (3:36,599,424–36,602,828) in 
BFMI mice (available from NCBI Sequence Read Archive 
(SRA) PRJNA717237). This deletion also leads to the loss 
of a binding site for the CCCTC-binding factor (CTCF). 
This CTCF-element in intron 8 was initially found by map-
ping DNase1 hypersensitive sites and by CTCF ChIP-Seq 
experiments in embryonic stem cells (Stadler et al. 2011). 
Such a CTCF-element may act as an insulator that is able to 
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block the activity of enhancers through modification of the 
3D DNA structure or act as a promoter activator or repressor 
(Phillips and Corces 2009). The binding of a CTCF-insulator 
binding protein was verified via the ChIP-Seq method (Chen 
et al 2008). ChIP-Seq can unveil a high range of binding 
sites for effectors such as CTCF-element, as it can recognize 
binding sites which exist at repetitive elements (Chen et al. 
2008). Repetitive elements also occur around the CTCF-
element in the deleted Bbs7 intron region. Re-mapping of 
the experimental data of Chen et al. in embryonic stem cells 
to the current genome of the mouse showed that CTCF binds 
indeed in intron 8 to the region of the deletion in the BFMI 
line (Ferrai et al. 2017).
In this study, the targeted generation of the BFMI deletion 
in intron 8 of Bbs7 using CRISPR/Cas9 (Ran et al. 2013) 
combined with complementation tests were used to identify 
the genetic effect of the deleted intron 8 region of Bbs7 on 
the development of obesity.
Materials and methods
Mouse populations
The Berlin Fat Mouse Inbred line 860-12 (BFMI) was used 
as our model for juvenile obesity. The line C57BL/6NCrl 
(B6N, Charles River Laboratories, Sulzfeld, Germany) 
served as lean control. These two lines have been used 
before for mapping the juvenile obesity QTL on mouse chro-
mosome 3 (Neuschl et al. 2010; Arends et al. 2016).
CRISPR/Cas9
Whole genome sequencing showed a deletion of 1578 bp 
(3:36,599,424–36,602,828) in intron 8 of Bbs7 in BFMI 
mice. This deletion was generated on a B6N background 
using CRISPR/Cas9 nuclease and a pair of single (sg) guide-
RNAs in single-cell mouse embryos as described in detail 
in (Wefers et al. 2017) and (Brandl et al. 2015). Consistent 
with the CRISPR/Cas9 endonuclease effect differences with 
respect to the strand breakpoints resulted in deletions of dif-
ferent lengths.
Briefly, Cas9 mRNA was prepared in a single step by 
in vitro transcription from plasmid pCAG-Cas9-162A 
linearized with AsiSI, AscI, and XbaI, using the mMes-
sage mMachine T7 Ultra kit (Life Technologies, Ambion, 
AM1345, Life Technologies, Carlsbad, USA) (omitting 
the polyadenylation step). Cas9-162A mRNA was iso-
lated using the Oligotex mRNA mini kit (cat No. 70022, 
Qiagen, Hilden, Germany). To produce the templates for 
sgRNA in vitro transcription, sgBbs7 were amplified by 
PCR from guide RNA containing plasmids. As target sites, 
we selected two 20 nucleotide sequences located upstream 
of the deleted DNA segment (sgBbs7-A1: CCA CTG TAT 
AGG GCG ACC AC, sgBbs7-A2: AGG AGT GCT TGC CAC 
TGT AT) and two sequences located downstream (sgBbs7-
B1: CTA CAT AAA GAA GAG AGG TT, sgBbs7-B2: TAG 
TCT GTA AAT CTC TTC AG).
1 µg template DNA was used for in vitro transcrip-
tion using the Megashortscript kit (Ambion, cat No. 
AM1354) followed by the MEGAclear kit (Ambion, cat 
No. AM1908) for RNA purification. RNAs and targeting 
vectors were diluted in microinjection buffer (10 mM Tris, 
0.1 mM EDTA, pH 7.2) to the indicated working concen-
trations, filtrated through a centrifugal filter (Ultrafree, 
PFTE, Millipore, cat. no. UFC30LG25) and stored in sin-
gle-use aliquots at − 80 °C. For microinjections, zygotes 
were obtained by mating of C57BL/6 N males with super-
ovulated C57BL/6 N females (Charles River, Sulzbach, 
Germany). Injected zygotes were transferred into pseudo-
pregnant NMRI female mice to obtain live pups.
Sanger sequencing was performed to identify the exact 
DNA-sequence breakpoints (Fig. 1). All positions men-
tioned in this paper are based on GRCm38.p6 (Ensembl 
release 102).
The modified mouse lines were named C57BL/6N-
Bbs7emI8∆*, where emI8∆* refers to an endonuclease-
mediated deletion of a specific part of intron 8. Two male 
mice with partial deletions in intron 8 of the Bbs7 gene, 
comparable to the BFMI allele, were generated. These 
mice were used as founders for two separate and independ-
ent pedigrees. In each pedigree C57BL/6N-Bbs7emI8∆* 
founder mice were initially crossed with BFMI and B6N 
mice. Subsequent generations were produced by mating 
of siblings. We named the families with the obtained 
deletions I8∆1 (995  bp, 3:36,599,695–36,600,690) 
and I8∆2 (1,272  bp; 3:36,599,578–36,600,850). Both 
C57BL/6N-Bbs7emI8∆* mice and BFMI (1,578  bp; 
36,599,687–36,601,265) share the deletion in intron 8 
between 36,599,695 and 36.600,850 (Fig. 1). Two inde-
pendent families were used since complementation in one 
of the two might allow to fine map which part of the dele-
tion might be causal. All deletions caused the loss of a 
CTCF-binding site located at 3:36,599,801–36,600,200. 
Both male and female animals were included in the 
analysis.
Husbandry conditions
All mice were maintained under conventional conditions and 
a 12:12 h light:dark cycle (lights on from 6 a.m. to 6 p.m.) at 
a temperature of 22 ± 2 °C. Animals had ad libitum access 
to food and water. The mice were fed with a rodent standard 
diet (V1534-000 ssniff R/M-H; Ssniff Spezialdiäten GmbH, 
Soest, Germany).
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Phenotyping
Total fat mass and total lean mass were determined in non-
anesthetized male and female mice at 10 weeks by quantita-
tive magnetic resonance (QMR) using the EchoMRI whole 
body magnetic resonance analyzer (Echo Medical Systems, 
Houston, TX, USA) (Wagener et al. 2006). QMR measure-
ments were performed in duplicates and the mean was used 
for further analyses. The ratio of total fat to total lean mass 
at 10 weeks (fat-to-lean ratio) was used to characterize the 
obese phenotype. Generations 7 to 14 of both independent 
families (I8∆1 and I8∆2) were analyzed in this paper for 
complementation, see supplemental Table 1 for an overview 
of numbers of animals (males/females) in each generation.
Genotyping
DNA was extracted from ear punches. Since three alleles 
occurred in our pedigrees, we generated a multiplex PCR 
system that allowed us to simultaneously genotype the BFMI 
and B6N alleles and the deletion alleles I8∆1 or I8∆2 (Sup-
plementary Table 2). Using two forward and one reverse 
primer, we could distinguish all three alleles within each 
pedigree (BFMI, B6N, pedigree-specific CRISPR/Cas9 
deleted alleles I8∆1 or I8∆2).
Data analysis and complementation tests
Phenotype and genotype data were analyzed using the R 
Project for Statistical Computing v4.0.2 (The R Develop-
ment Core Team 2005). Phenotype measurements were 
adjusted for generation and sex since these external factors 
showed a significant effect on the phenotype. We performed 
an ANOVA test with the general linear model (corrected for 
sex and generation) to identify significant differences of the 
fat-to-lean ratio between genotype classes. Subsequently, a 
Welch’s t-test was used for pairwise group comparison. Dif-
ferences between genotype classes were considered statisti-
cally significant at P < 0.05.
Results
Covariates (sex, generation, litter size)
A linear model was used to investigate the influence of 
sex, generation, and litter size on the phenotype. The 
most significant effect was sex (P(I8∆1) = 2.20 ×  10–16; 
P(I8∆2) = 5.95 ×  10–14) followed by the generation effect 
(P(I8∆1) = 0.066; P(I8∆2) = 0.002). Litter size showed 
no significant effect on the phenotype in both families 
(P(I8∆1) = 0.158; P(I8∆2) = 0.453). As such, we corrected the 
fat-to-lean ratio for sex and generation. The adjusted fat-
to-lean ratio was used in further complementation testing.
Family 1 (I8∆1)
The I8∆1 allele was tested for complementation with 
the BFMI allele. B6N allele carriers were used as lean 
reference. Homozygous B6N carriers were the smallest 
genotype group (8 animals; mean: 0.112 ± 0.048). How-
ever, there was no difference to the other two genotypes 
carrying one B6N allele (P(B6N/B6N vs. BFMI/B6N) = 0.879; 
P(B6N/B6N vs. I8∆1/B6N) = 0.404). By taking this into account, 
combined with the knowledge that the effect is a recessive 
Fig. 1  Deletions in the intron 8 of Bbs7. Comparison of B6N (refer-
ence) to the naturally occurring deletion in the BFMI (top), and the 
two artificial CRISPR/Cas9 introduced deletions I8∆1 and I8∆2. 
Please, note that the Bbs7 gene is on the negative strand, as such 
Exon 9 is in front of Exon 8
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effect, these genotypes were merged (x/B6N) to create a 
larger reference panel consisting of 70 animals (mean: 
0.096 ± 0.035).
The two complementing genotypes BFMI/I8∆1 
and I8∆1/I8∆1 also showed no significant difference 
(P(I8∆1/I8∆1 vs. BFMI/I8∆1) = 0.971) in fat-to-lean ratio and 
were also merged into a single complementation group 
(y/I8∆1) consisting of 440 animals (mean: 0.122 ± 0.047). 
The positive control group (BFMI/BFMI) of family 1 
(I8∆1) contains 31 animals.
Complementation was investigated by comparing the 
y/I8∆1 group to the positive control (BFMI/BFMI) and 
the negative control (x/B6N). This comparison showed 
a significant (P(y/I8∆1 vs. x/B6N) = 4.25 ×  10–7) increase 
in fat-to-lean ratio from 0.096 for x/B6N animals to 
0.122 for y/I8∆1 animals. However, homozygous BFMI 
(mean: 0.268 ± 0.102) animals showed a significantly 
(P(BFMI/BFMI vs. y/I8∆1) = 3.62 ×  10–9) higher fat-to-lean ratio 
compared to the y/I8∆1 group, pointing to a partial com-
plementation (Fig. 2a, Supplementary Table 3).
The effects size, relative to the x/B6N group, showed 
that the I8∆1 allele increases the fat-to-lean ratio by 0.026, 
while the homozygous BFMI animals showed an increase 
of 0.172. This indicates that the I8∆1 allele explains 
around 15.1% of the BFMI effect.
Family 2 (I8∆2)
Results from family 2 verify the results obtained in 
family 1. However, it should be noted that the over-
all fat-to-lean ratio in family 2 is significantly lower 
than in family 1 (fat-to-lean(family2 vs. family1) =  − 23.6%, 
P(family2 vs. family 1) = 5.68 ×  10–13).
Similar to family 1, we also observed no difference 
between animals carrying one or more B6N alleles 
(P(B6N/B6N vs. BFMI/B6N) = 0.428; P(B6N/B6N vs. I8∆2/B6N) = 0.953). 
Also, for the complementation group no difference was 
observed (P(I8∆2/I8∆2 vs. BFMI/I8∆2) = 0.146). Merging 
of groups led to a sample size of 68 animals in the x/
B6N group and 310 animals in the y/I8∆2 group. Fur-
thermore, the same pattern as in family 1 was seen: x/
B6N was the group with the lowest fat-to-lean ratio 
(0.074 ± 0.028), BFMI/BFMI showed the highest fat-to-
lean ratio (0.204 ± 0.112), and a significant increase of 
the y/I8∆2 group (0.091 ± 0.032) compared to the x/B6N 
group (P(y/I8∆2 vs. x/B6N) = 3.17 ×  10–5) was observed (Sup-
plementary Table 4). The I8∆2 allele showed a 13.1% par-
tial complementation of the BFMI allele, an effect very 
similar to the I8∆1 allele.
The uncorrected data are also shown in the supplemen-
tal files (Supplemental Figs. 1 and 2).
Fig. 2  a 541 animals of generations 7–14 were analyzed in pedi-
gree I8∆1. The gender breakdown is given on top of the x-axis for 
every genotype (m males; f females). The phenotype on the y-axis 
was corrected for sex and generation. The homozygous BFMI 
genotype showed the highest fat-to-lean ratio of 0.268 ± 0.102. 
The y/I8∆1 (grouping of I8∆1/I8∆1 and BFMI/I8∆2) showed a 
fat-to-lean ratio of 0.122 ± 0.047, which was significantly lower 
(P(BFMI/BFMI vs. y/I8∆1) = 3.62 ×  10–9) than in BFMI homozygous mice, 
but also significantly higher significant (P(y/I8∆1 vs. x/B6N) = 4.25 ×  10–7) 
than genotypes of the reference group x/B6N (0.096 ± 0.035) (x/
B6N is the grouping of B6N/B6N, BFMI/B6N, and I8∆1/B6N). 
The effect of the I8∆1 allele is 15.1% of the BFMI allele. b 408 
mice of generation 7–14 were analyzed in pedigree I8∆2. The phe-
notype on the y-axis was corrected for sex and generation. The 
homozygous BFMI genotype showed the highest fat-to-lean ratio 
of 0.204 ± 0.112. The y/I8∆2 complementation group showed a 
fat-to-lean ratio of 0.091 ± 0.032, which was significantly lower 
(P(BFMI/BFMI vs. y/I8∆2) = 5.54 ×  10–6) than in the BFMI homozygous 
mice, but significantly higher (P(y/I8∆2 vs. x/B6N) = 3.17 ×  10–5) than 
genotypes containing the B6N allele (x/B6N) with a fat-to-lean ratio 
of 0.074 ± 0.028. The effect of the I8∆2 allele is 13.1% of the BFMI 
allele
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Discussion
Both of the CRISPR/Cas9 modified mice and the BFMI 
mouse share the loss of a region in intron 8 of Bbs7 
between 36,599,695 and 3,600,960 base pairs on chro-
mosome 3 containing a CTCF-element. The deletion 
of a CTCF-element is known to affect the 3D chromo-
somal structure (Phillips and Corces 2009) and as a result 
changes the accessibility of transcription factor binding 
sites (Ohlsson et al. 2001). Previously, it was observed 
that the Bbs7 expression in BFMI mice is significantly 
reduced compared to the expression of Bbs7 in B6N 
mice (Arends et al. 2016). Previous experiments on Bbs7 
knockout mice showed obesity as one of the phenotypes 
observed in these mice (Zhang et al. 2013). The deleted 
CTCF-element in intron 8 in BFMI, I8∆1, and I8∆2 may 
be responsible for reducing Bbs7 transcription levels, 
which might cause obesity by influencing fat deposition.
Since we observed only a partial complementation in 
the I8∆1 and I8∆2 families, one (or more) other vari-
ants need to be involved in causing the juvenile obesity 
phenotype of BFMI mice. Sequence data provided evi-
dence for additional sequence variation between BFMI 
and B6N inside the jObes1 locus. Eventually, one of the 
other sequence variants in BFMI in addition to the dele-
tion in intron 8 is required for full complementation of 
the BFMI allele effect. These additional sequence variants 
did not occur in the CRISPR/Cas9 modified B6N mice. 
The additional sequence variants in BFMI are likely in 
close proximity to Bbs7, since otherwise recombinations 
would have caused BFMI variants in the background of 
the modified B6N mice in some animals of the I8∆1, 
and I8∆2 families. This would have led to a full comple-
mentation for some of the mice, which was not observed 
in our study. The additional sequence variants were not 
tested in this study. Therefore, we cannot exclude variants 
outside of the jObes1 locus that could affect or modulate 
the juvenile obesity phenotype in BFMI mice directly or 
in interaction with the deleted region in intron 8 of Bbs7.
Several other mouse lines harbor a similar deletion 
found in BFMI mice. Some of these were previously 
investigated for complementation (NZO and AKR/J) 
(Arends et al. 2016). No complementation with NZO and 
AKR/J was detected in the 2016 study, and there it was 
concluded that the intron 8 deletion was not causal for 
the juvenile obesity. With the current finding of a partial 
complementation by I8∆1 and I8∆2, we revisit the intron 
8 effect, and now show that part of the juvenile obesity 
seen in BFMI mice can be explained by the deletion in 
intron 8. The previous study missed this partial comple-
mentation effect since the sample sizes used were only 
suitable for investigating full complementation.
Conclusion
We show that various partial deletions (I8∆1 and I8∆2) in 
intron 8 of Bbs7 are able to partially complement the BFMI 
allele at the jObes1 locus, seen by an increase in the fat-
to-lean ratio. Both I8∆1 and I8∆2 alleles show a recessive 
effect on the fat-to-lean ratio similar to the BFMI allele. The 
strengths of complementation of the I8∆1 and I8∆2 alleles 
are similar. By aligning the three deletions (I8∆1, I8∆2, and 
BFMI) we found the only common feature shared between 
the three deletions was a CTCF-element. Additionally, we 
conclude that another sequence variant at the jObes1 locus 
in BFMI is essential to show the full effect on juvenile obe-
sity as seen in BFMI mice. This is because (A) we see only 
partial complementation meaning another variant should be 
present, and (B) we know this variant needs to be close to 
the deletion otherwise recombinations in the two pedigrees 
would have caused around 50% of offspring with the com-
plementation genotypes to show full complementation due 
to inheritance of the second factor in the genetic background.
Supplementary Information The online version contains supplemen-
tary material available at https:// doi. org/ 10. 1007/ s00335- 021- 09938-5.
Acknowledgements FK and KM were supported by the Deutsche 
Forschungsgemeinschaft (DFG) (BR 1285/12). We thank Angelika 
Ackermann for her assistance in the lab, Ben Gerhardt, Maximilian 
Sprechert, and Erik Leipe for genotyping. Marion Bütow, Michael 
Modrow, and Jens Fuchs for taking care of the animals and measuring 
phenotypes.
Author contributions FK and KM contributed equally, and both should 
be considered first authors. FK performed the statistical analysis, QMR 
measurements, and drafted the manuscript and figures. KM conducted 
most of the experiments, drafted the manuscript and figures. MD per-
formed QMR measurements and provided feedback on the manuscript. 
DH critical reading of the manuscript and feedback. RK was respon-
sible for CRISPR/Cas9 experiments and feedback on the manuscript. 
DA performed the statistical analysis, critical reading of the manu-
script, and feedback. GB designed the experiment, critical reading of 
the manuscript, and feedback.
Funding Open Access funding enabled and organized by Projekt 
DEAL.
Data and code availability Scripts and raw data are available at https:// 
github. com/ Flori anKra use/ Bbs7- compl ement ation.
Declarations 
Conflict of interest The authors declare no conflict of interest.
Ethical approval All experimental treatments of mice were approved 
by the German Animal Welfare Authorities (Approval No. G0162/12, 
G0292/15, G0302/15 and G0174/19).
Open Access This article is licensed under a Creative Commons 
Attribution 4.0 International License, which permits use, sharing, 
 F. Krause et al.
1 3
adaptation, distribution and reproduction in any medium or format, 
as long as you give appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons licence, and indicate 
if changes were made. The images or other third party material in this 
article are included in the article's Creative Commons licence, unless 
indicated otherwise in a credit line to the material. If material is not 
included in the article's Creative Commons licence and your intended 
use is not permitted by statutory regulation or exceeds the permitted 
use, you will need to obtain permission directly from the copyright 
holder. To view a copy of this licence, visit http:// creat iveco mmons. 
org/ licen ses/ by/4. 0/.
References
Arends D, Heise S, Kärst S et al (2016) Fine mapping a major obe-
sity locus (jObes1) using a Berlin Fat Mouse × B6N advanced 
intercross population. Int J Obes 40:1784–1788. https:// doi. org/ 
10. 1038/ ijo. 2016. 150
Brandl C, Ortiz O, Röttig B et al (2015) Creation of targeted genomic 
deletions using TALEN or CRISPR/Cas nuclease pairs in one-
cell mouse embryos. FEBS Open Bio 5:26–35. https:// doi. org/ 
10. 1016/j. fob. 2014. 11. 009
Chen X, Xu H, Yuan P et al (2008) Integration of external signaling 
pathways with the core transcriptional network in embryonic stem 
cells. Cell 133:1106–1117. https:// doi. org/ 10. 1016/j. cell. 2008. 04. 
043
Ferrai C, Torlai Triglia E, Risner-Janiczek JR et al (2017) RNA pol-
ymerase II primes polycomb-repressed developmental genes 
throughout terminal neuronal differentiation. Mol Syst Biol 
13:946. https:// doi. org/ 10. 15252/ msb. 20177 754
Hantschel C, Wagener A, Neuschl C et al (2011) Features of the meta-
bolic syndrome in the Berlin Fat Mouse as a model for human 
obesity. Obes Facts 4:270–277. https:// doi. org/ 10. 1159/ 00033 
0819
Heise S, Trost J, Arends D et al (2016) High variability of insulin 
sensitivity in closely related obese mouse inbred strains. Exp 
Clin Endocrinol Diabetes 124:519–528. https:// doi. org/ 10. 
1055/s- 0042- 109261
Meyer CW, Wagener A, Rink N et al (2009) High energy digestion 
efficiency and altered lipid metabolism contribute to obesity in 
BFMI mice. Obesity 17:1988–1993. https:// doi. org/ 10. 1038/ oby. 
2009. 124
Neuschl C, Hantschel C, Wagener A et al (2010) A unique genetic 
defect on chromosome 3 is responsible for juvenile obesity in the 
Berlin Fat Mouse. Int J Obes 34:1706–1714. https:// doi. org/ 10. 
1038/ ijo. 2010. 97
Ohlsson R, Renkawitz R, Lobanenkov V (2001) CTCF is a uniquely 
versatile transcription regulator linked to epigenetics and disease. 
Trends Genet 17:520–527
Phillips JE, Corces VG (2009) CTCF: master weaver of the genome. 
Cell 137:1194–1211
Ran FA, Hsu PD, Wright J et al (2013) Genome engineering using the 
CRISPR-Cas9 system. Nat Protoc 8:2281–2308. https:// doi. org/ 
10. 1038/ nprot. 2013. 143
Stadler MB, Murr R, Burger L et al (2011) DNA-binding factors 
shape the mouse methylome at distal regulatory regions. Nature 
480:490–495. https:// doi. org/ 10. 1038/ natur e10716
The R Development Core Team (2005) R: A language and environ-
ment for statistical computing. In: R foundation for Statistical 
Computing
Wagener A, Schmitt AO, Aksu S et al (2006) Genetic, sex, and diet 
effects on body weight and obesity in the Berlin Fat Mouse Inbred 
lines. Physiol Genom 27:264–270. https:// doi. org/ 10. 1152/ physi 
olgen omics. 00225. 2005
Wefers B, Bashir S, Rossius J et al (2017) Gene editing in mouse 
zygotes using the CRISPR/Cas9 system. Methods 121–122:55–
67. https:// doi. org/ 10. 1016/j. ymeth. 2017. 02. 008
Zhang Q, Nishimura D, Vogel T et al (2013) BBS7 is required for 
BBSome formation and its absence in mice results in Bardet-Biedl 
syndrome phenotypes and selective abnormalities in membrane 
protein trafficking. J Cell Sci 126:2372–2380. https:// doi. org/ 10. 
1242/ jcs. 111740
Publisher's Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
